pillbase.ru

TALTZ

Active substance: ixekizumab

INJECTION, SOLUTION · IXEKIZUMAB 20 mg/.25mL

United StatesActive

Marketing holder: Eli Lilly and Company

Verified 2026-10-09 · openFDA NDC

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
RU 2
  • ТАЛС®
    раствор для подкожного введения, 80 мг, 1 мл (original in Russian, GRLS)
    ЛП-№(012301)-(РГ-RU)
    Общество с ограниченной ответственностью "Свикс Хэлскеа" (ООО "Свикс Хэлскеа")
  • ТАЛС®
    раствор для подкожного введения, 80 мг/мл, 1 мл (original in Russian, GRLS)
    ЛП-005200
    Общество с ограниченной ответственностью "Свикс Хэлскеа" (ООО "Свикс Хэлскеа")
EU 1
  • Taltz
    ixekizumab
    EMEA/H/C/003943
    Eli Lilly and Company (Ireland) Limited
Import and control

Control by country

  • Russiaprescription only

    Source: GRLS (Russian state register) · record 01a120c3-cbe8-7860-9462-77048a4657ee,01a120c5-cafd-7f15-af58-fc17d00d2b6e;count=2 · valid from 2026-10-09 · verified 2026-10-09

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208c-486e-711f-8e16-b3ff22c2f7c5,01a1208d-e913-707c-abef-8e690c9a699d,01a12095-708c-7b2e-9aa8-2b2b870c02bd,01a12095-7494-7da5-b07d-d69b8e34c177;count=4 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
0002-8900
Registration status
Active
Dispensing
Prescription only
Route
SUBCUTANEOUS
Sources
  • product · openFDA NDC · 0002-8900 · Verified 2026-10-09 · open in source
  • registration_status · openFDA NDC · 0002-8900 · Verified 2026-10-09 · open in source
  • ingredients.0 · openFDA NDC · 0002-8900 · Verified 2026-10-09 · open in source